Risk Factors Associated With Faster Time to Vancomycin-Resistant Enterococci Positivity in Acute Myeloid Leukemia Patients Undergoing Initial Intensive Induction Chemotherapy With Cytarabine and Idarubicin
Author(s) -
Ronald Heisel,
Robert M Sutton,
Gerard P. Mascara,
Daniel G. Winger,
Seah H. Lim,
David R. Weber,
LouiseMarie Oleksiuk
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw172.154
Subject(s) - idarubicin , medicine , cytarabine , vancomycin , induction chemotherapy , myeloid leukemia , chemotherapy , oncology , staphylococcus aureus , biology , bacteria , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom